Dr. Joseph Szekely

• Leading the Licensing and supporting Portfolio Management and Marketing, BD-, M&A- globally • Leading strategic commercial- and technical negotiations • Supporting portfolio and market analysis, partner selection, business case development, due diligence, Rx, Branded Medicines, Value Added Generics, OTC and Food Supplements • Branding Strategies, Promotional campaigns and customers insight programs • Process implementation projects • CPHI, EUROPLX, VITAFOODS. • CEE, CIS, RU. CNS, CVM, Oncology, WH.

Negotiation of Global Quality and Business Agreements; implementation of Contracting Strategies and Templates in line with Corporate Fund-flow Business Processes for Commercial Manufacturing, Material movement/purchasing, Logistics Partners, MAH, in/out-licensing and divestment projects. Support Global Supply Chain Projects (e.g. Batch Traceability, Serialization, Product Security, KPI monitoring, Cold-Change improvement, Change Control excellence, and Business Process optimization). 12,000 SKUs Globally.

Managed a global team and multiple projects in Product Development, Contract Manufacturing, Technology Transfers, site and artwork submissions and Supply Planning for API, sterile DP fill and Packaging of commercial products

As an expert in Technical Operations, R&D and Industrialization and Global Operations (Sourcing, Contracting and Finance) I expanded the organization with commercial management skills. At the merger of Celltech UK (Biotech, NBE) and UCB Pharma (Chemicals, NCE) accountable for transferring Projects-, Technologies and cGxP Partner Management from discovery (UK) to the expanding Belgian and Swiss Biotech Technical Operations. Built and managed Project teams (of 6) with 7-11 direct reports.

Investigator in projects with worldwide influence in supporting scientific knowledge for Drug Development and Biomarker Detections for a variety of Therapeutic Areas. In interest of the World Health Organization and the National Institute of Health, Global Impact on Health-Care solutions. • Introduction of R&D strategies. • Establishment of multidisciplinary research groups • Bioanalytical Technologies • DNA/RNA, Nucleotide and Protein Research. • Synthetic Development, Proposed Drug Solutions.

• Increasing the portfolio projects and raised funds to deliver R&D knowledge in the description of the Biochemical processes and Drug Development. • Development of knew technologies in Synthetic Chemistry, Isolation and Purification of Biotech Products, Biochemistry, Bioanalytics and Process Analytics. • Enhancement of International and Industrial project participations.

Leading the Manufacturing Development and Quality Assurance Teams in the Eastern-European Region I worked in close-cooperation with the Marketing Division and Health Authorities to enlarge the number of products we could support to the Medical Device Market. I participated in Technology and Site transfers from Western-Europe to Developing countries. • Quality Management • Process Controls • Product Development • Proposal of Modern Products to clients in Health-Care

• Graduated with International Honours • Development and Execution of self-raised R&D projects • Member of the American Chemical Society • Biotechnology, Synthetic Chemistry • DNA/RNA/Protein research

• Translations and Presentations in Sciences, Technology and Business Administration

• International Scholarships to the USA and European Research Institutions • NMR, MS, Medical Diagnostics • Synthetic Development